Research showing that patients who received injections of Juvéderm Volbella in the tear trough area or lips had a higher than expected incidence of late cutaneous reactions was the most-read aesthetic dermatology article on Healio.com during the first six months of 2016.
Other widely read articles included a report that a record number of patients underwent lip augmentations in 2015, and research finding that patients receiving hyaluronic acid dermal filler showed increased epidermal layers and collagen fibers at follow-up:
Incidence of late reactions to Juvéderm Volbella higher than expected
Patients in Israel who received injections of Juvéderm Volbella in the tear trough area or lips had a higher than expected incidence of late cutaneous reactions, according to study results.
Researchers examined the medical records of 400 patients (360 women; average age, 49.6 years) who were treated with Juvéderm Volbella (hyaluronic acid; HA-Vb) filler at four medical centers in Israel. Read more
VIDEO: Amy J. McMichael, MD, reviews new topical treatment for hair loss
WASHINGTON – In a video perspective, Amy J. McMichael, MD, discusses research she reviewed on qilib, a new over-the-counter topical treatment for hair loss.
Amy J. McMichael
The qilib hair care line (Galderma Laboratories) uses a solution formulated with botanicals, including an onion extract as its active ingredient, in conjunction with 2% minoxidil for women and 5% minoxidil for men. It was introduced at the American Academy of Dermatology Annual Meeting. Watch video
ASPS: Lip augmentation procedures see record increase in 2015
There were a record number of patients undergoing lip augmentation procedures in 2015, according to a press release from the American Society of Plastic Surgeons.
David H. Song
“We live in the age of the selfie, and because we see images of ourselves almost constantly on a social media, we’re much more aware of how our lips look,” David H. Song, MD, president of the American Society of Plastic Surgeons (ASPS), stated in the release. Read more
Allergan acquires rights to potential topical treatment for under eye bags
Allergan plc announced in a press release that it has acquired Topokine Therapeutics, a biotechnology company focused on developing topical medicines for fat reduction.
Terms of the purchase include an upfront payment from Allergan of $85 million and success-based developments and sales milestones of XAF5, a first-in-class topical agent in late-stage development for treating steatoblepharon, or under eye bags, according to the release. Read more
BLOG: Cosmetic pearls from the AAD annual meeting
Kimberly J. Butterwick, MD, a dermatologist in private practice in San Diego, discussed aesthetic highlights of the annual meeting of the American Academy of Dermatology in Washington, D.C.
Kimberly J. Butterwick
Some of the highlights of this meeting included live demonstrations of a new lifting technique with poly-l-lactic acid absorbable sutures. Read more
Hyaluronic acid filler increases epidermal layers, collagen fibers
Patients who received hyaluronic acid dermal filler showed increased epidermal layers and collagen fibers at follow-up, according to recent research.
“In this study, the clinical and histological study of [hyaluronic acid] filler injections on photoaged faces revealed clinical improvement and skin remodeling after the procedure, with a long follow-up period,” Fabiana Braga França Wanick, MD, MSc, from the department of medical sciences at Fluminense Federal University in Niterói, Brazil, and colleagues wrote in their study. Read more